Your browser doesn't support javascript.
loading
Psoriasis risk after beta-blocker exposure: Description of a pharmacovigilance signal.
Azzouz, Brahim; De Guizelin, Apolline; Lambert, Aude; Fresse, Audrey; Morel, Aurore; Trenque, Thierry.
Affiliation
  • Azzouz B; Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, Reims, France.
  • De Guizelin A; EA 3797 Vieillissement, Fragilité, Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France.
  • Lambert A; Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, Reims, France.
  • Fresse A; Regional Pharmacovigilance Centre, Strasbourg University Hospital, Strasbourg, France.
  • Morel A; Regional Pharmacovigilance Centre, Nancy University Hospital, Nancy, France.
  • Trenque T; Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, Reims, France.
Br J Clin Pharmacol ; 88(8): 3813-3818, 2022 08.
Article in En | MEDLINE | ID: mdl-35352377
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pharmacovigilance Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pharmacovigilance Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: France Country of publication: United kingdom